logo
Select company
Select metric
$ -12.88MEarning Before Interest & Taxes (EBIT)
VS
Market
28
Sector
60
Industry
74
History
28
$ 0.38Close
$ 0.17 - $ 1.41 52-Week Range
Ticker Information

Ticker

PCSA

Company Name

PROCESSA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROCESSA PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PCSA - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -12.88M
3/31/2025$ -11.96M
12/31/2024$ -11.85M
9/30/2024$ -11.53M
6/30/2024$ -10.22M
3/31/2024$ -9.83M
12/31/2023$ -11.12M
9/30/2023$ -21.73M
6/30/2023$ -25.67M
3/31/2023$ -28.22M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROCESSA PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -5.84M.
  • Over the past 5 years, PROCESSA PHARMACEUTICALS INC's average EBIT has been $ -15.74M.
  • The median EBIT for PROCESSA PHARMACEUTICALS INC during this period was $ -13.93M
  • PROCESSA PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ -5.84M.
  • The lowest EBIT recorded by PROCESSA PHARMACEUTICALS INC in the same timeframe $ -28.22M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

PCSA - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -28.22M

Minimum

Mar 31, 2023

$ -5.84M

Maximum

Sep 30, 2020

$ -15.74M

Average

$ -13.93M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M